Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566317 · ClinicalTrials.gov registry record · NA
Stand & Move at Work
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 630
- Enrollment target
NCT02566317: Completed NA study, sponsored by Arizona State University.
NCT02566317 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 630 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566317, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 630 participants
- Enrollment target
Study Summary
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.
Primary Outcome
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Interventions
- DEVICE Sit-Stand workstation
- BEHAVIORAL Move
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2016-01-15 |
| Est. Completion | 2018-12-15 |
| Phase | NA |
What the finished NCT02566317 record still lists
NCT02566317 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Sit-Stand workstation is the first listed.
NCT02566317 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566317 about?
NCT02566317 is a clinical study titled "Stand & Move at Work". A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.
What is the current status of trial NCT02566317?
This trial is currently completed. It is a NA study. The enrollment target is 630 participants. The study started on 2016-01-15. Estimated completion is 2018-12-15.
What interventions are being tested in trial NCT02566317?
The interventions under investigation include: Sit-Stand workstation (DEVICE), Move (BEHAVIORAL).
Who is sponsoring clinical trial NCT02566317?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566317's enrollment target sits among peer trials
630 159th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI